tradingkey.logo

Nexgel Inc

NXGL

2.629USD

+0.059+2.31%
Horário de mercado ETCotações atrasadas em 15 min
20.13MValor de mercado
PerdaP/L TTM

Nexgel Inc

2.629

+0.059+2.31%
Mais detalhes de Nexgel Inc Empresa
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. It also specializes in eye and eyelash consumer products.
Informações da empresa
Código da empresaNXGL
Nome da EmpresaNexgel Inc
Data de listagemDec 22, 2021
CEOMr. Adam Levy
Número de funcionários19
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 22
Endereço2150 Cabot Blvd West,
CidadeLANGHORNE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal19047
Telefone12157028550
Sitehttps://nexgel.com/
Código da empresaNXGL
Data de listagemDec 22, 2021
CEOMr. Adam Levy
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
156.66K
+0.03%
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
106.66K
--
Mr. Joseph F. (Joe) McGuire
Mr. Joseph F. (Joe) McGuire
Chief Financial Officer
Chief Financial Officer
4.08K
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Mr. Adam Levy
Mr. Adam Levy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Scott R. Henry
Mr. Scott R. Henry
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steven Mark Glassman
Mr. Steven Mark Glassman
Independent Chairman of the Board
Independent Chairman of the Board
156.66K
+0.03%
Dr. Jerome B. Zeldis, M.D., Ph.D.
Dr. Jerome B. Zeldis, M.D., Ph.D.
Independent Director
Independent Director
106.66K
--
Mr. Joseph F. (Joe) McGuire
Mr. Joseph F. (Joe) McGuire
Chief Financial Officer
Chief Financial Officer
4.08K
--
Mr. Nachum Stein
Mr. Nachum Stein
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Mr. Adam Levy
Mr. Adam Levy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sex, 23 de mai
Atualizado em: sex, 23 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Stein (John Nachum)
6.03%
Levy (Adam R)
4.90%
Evernest Financial Advisors, LLC
3.67%
Glassman (steven mark)
2.05%
Henry (Scott Robert)
1.69%
Other
81.66%
Investidores
Investidores
Proporção
Stein (John Nachum)
6.03%
Levy (Adam R)
4.90%
Evernest Financial Advisors, LLC
3.67%
Glassman (steven mark)
2.05%
Henry (Scott Robert)
1.69%
Other
81.66%
Tipos de investidores
Investidores
Proporção
Individual Investor
16.11%
Investment Advisor
6.21%
Investment Advisor/Hedge Fund
1.61%
Hedge Fund
1.07%
Family Office
0.14%
Venture Capital
0.13%
Other
74.72%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
34
1.92M
25.13%
-119.08K
2025Q1
37
2.17M
29.57%
+164.76K
2024Q4
32
1.98M
26.34%
+256.49K
2024Q3
30
1.74M
25.65%
+126.36K
2024Q2
29
1.63M
25.29%
+39.41K
2024Q1
28
1.57M
26.08%
+59.90K
2023Q4
28
1.51M
25.63%
-46.18K
2023Q3
30
1.53M
26.03%
-38.00K
2023Q2
29
1.53M
25.96%
+67.69K
2023Q1
26
1.40M
25.19%
+48.62K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Stein (John Nachum)
461.46K
6.03%
-48.20K
-9.46%
Apr 30, 2025
Levy (Adam R)
375.34K
4.9%
-6.00K
-1.57%
Jun 11, 2025
Evernest Financial Advisors, LLC
224.67K
2.94%
+224.67K
--
Mar 31, 2025
Glassman (steven mark)
156.66K
2.05%
+40.00
+0.03%
Apr 30, 2025
Henry (Scott Robert)
129.05K
1.69%
-3.00K
-2.27%
Jun 13, 2025
Zeldis (Jerome B)
106.66K
1.39%
--
--
Apr 30, 2025
Morgan Stanley Smith Barney LLC
87.80K
1.15%
--
--
Mar 31, 2025
Renaissance Technologies LLC
81.63K
1.07%
-76.70K
-48.44%
Mar 31, 2025
Geode Capital Management, L.L.C.
66.45K
0.87%
+6.30K
+10.48%
Mar 31, 2025
The Vanguard Group, Inc.
50.10K
0.65%
+127.00
+0.25%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI